Pathstone Family Office’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $217K | Buy |
+1,997
| New | +$217K | ﹤0.01% | 1464 |
|
|
2023
Q2 | – | Sell |
-1,833
| Closed | -$228K | – | 1242 |
|
|
2023
Q1 | $228K | Sell |
1,833
-2,577
| -58% | -$321K | ﹤0.01% | 1034 |
|
|
2022
Q4 | $662K | Buy |
4,410
+206
| +5% | +$30.9K | 0.01% | 971 |
|
|
2022
Q3 | $568K | Buy |
4,204
+2,641
| +169% | +$357K | 0.01% | 1024 |
|
|
2022
Q2 | $233K | Sell |
1,563
-386
| -20% | -$57.6K | 0.01% | 892 |
|
|
2022
Q1 | $332K | Buy |
1,949
+280
| +17% | +$47.7K | 0.01% | 707 |
|
|
2021
Q4 | $430K | Buy |
1,669
+259
| +18% | +$66.7K | 0.01% | 604 |
|
|
2021
Q3 | $385K | Buy |
1,410
+18
| +1% | +$4.92K | 0.01% | 597 |
|
|
2021
Q2 | $312K | Buy |
+1,392
| New | +$312K | 0.01% | 631 |
|
|
2021
Q1 | – | Sell |
-200
| Closed | -$16K | – | 730 |
|
|
2020
Q4 | $16K | Sell |
200
-100
| -33% | -$8K | ﹤0.01% | 748 |
|
|
2020
Q3 | $21K | Buy |
300
+100
| +50% | +$7K | ﹤0.01% | 469 |
|
|
2020
Q2 | $13K | Buy |
+200
| New | +$13K | ﹤0.01% | 478 |
|